Compounds > beta-(5-hydroxy-2-pyridyl)alanine
Page last updated: 2024-09-03

beta-(5-hydroxy-2-pyridyl)alanine and 9,10-dimethyl-1,2-benzanthracene

beta-(5-hydroxy-2-pyridyl)alanine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies

Compound Research Comparison

Studies
(beta-(5-hydroxy-2-pyridyl)alanine)		Trials
(beta-(5-hydroxy-2-pyridyl)alanine)		Recent Studies (post-2010)
(beta-(5-hydroxy-2-pyridyl)alanine)		Studies
(9,10-dimethyl-1,2-benzanthracene)		Trials
(9,10-dimethyl-1,2-benzanthracene)		Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene)
31056,01010772

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doi, S; Izawa, M; Katsuki, M; Kimura, M; Nishimura, S; Shindo-Okada, N; Takayama, S1

Other Studies

1 other study(ies) available for beta-(5-hydroxy-2-pyridyl)alanine and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
Inhibition of chemical carcinogenesis in vivo by azatyrosine.
    Cancer research, 1992, Mar-15, Volume: 52, Issue:6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Alanine; Animals; Antibiotics, Antineoplastic; Drug Screening Assays, Antitumor; Genes, ras; Methylnitrosourea; Mice; Mutation; Papilloma; Skin Neoplasms; Stomach Neoplasms

1992